Pharma Disease Strategy

A leading pharmaceutical company asked BCG to help develop a comprehensive strategy to become the leader in the treatment of a complex disease.  This disease is particularly challenging, characterized by significant unmet patient need and a highly uncertain, complex scientific landscape.

Despite a tremendous volume of research, there is no consensus on the cause of the disease and no drugs in the market to treat it.  BCG teamed with leaders from across our client’s R&D and commercial functions to develop a comprehensive strategy to succeed in the immediate term and to capitalize on opportunities from emerging science in the long term.

BCG is No. 3 on 2014 "Best Companies" List

For the fourth year in a row, BCG has been ranked in the top five of Fortune’s “100 Best Companies to Work For." more

BCG Digital VenturesBCG brings a first-of-its-kind offering, as BCG Digital Ventures aims to form strategic venture teams with clients in order to create and grow disruptive digital platforms.More

interview with ceo
TED@BCGView these remarkable examples of transformative thinking gathered from the groundbreaking partnership between TED and BCG. view